US Patent 9695224 Stabilized insulinotropic peptides and methods of use
Patent 9695224 was granted and assigned to Dana-Farber Cancer Institute on July, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9695224 Stabilized insulinotropic peptides and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.